2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process – High Priority Description: The percentage of episodes for patients 3 years andContinue reading “2025 #66 MIPS Measure Appropriate Testing for Pharyngitis”
CQMS Archive
2025 #65 MIPS Measure Appropriate Treatment for Upper Respiratory Infection (URI)
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process – High Priority Description: Percentage of episodes for patients 3 months of ageContinue reading “2025 #65 MIPS Measure Appropriate Treatment for Upper Respiratory Infection (URI)”
2025 #52 MIPS Measure Chronic Obstructive Pulmonary Disease (COPD): Spirometry Evaluation and Long-Acting Inhaled Bronchodilator Therapy
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description: Percentage of patients aged 18 years and older with a diagnosis ofContinue reading “2025 #52 MIPS Measure Chronic Obstructive Pulmonary Disease (COPD): Spirometry Evaluation and Long-Acting Inhaled Bronchodilator Therapy”
2025 #50 Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years and Older
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process – High Priority Description: Percentage of female patients aged 65 years and olderContinue reading “2025 #50 Urinary Incontinence: Plan of Care for Urinary Incontinence in Women Aged 65 Years and Older”
2025 #48 MIPS Measure Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description: Percentage of Female Patients Aged 65 Years and Older Who Were AssessedContinue reading “2025 #48 MIPS Measure Urinary Incontinence: Assessment of Presence or Absence of Urinary Incontinence in Women Aged 65 Years and Older”
2025 #47 MIPS Measure Advance Care Plan
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process – High Priority Description: Percentage of Patients Aged 65 Years and Older WhoContinue reading “2025 #47 MIPS Measure Advance Care Plan”
2025 #39 MIPS Measure Screening for Osteoporosis for Women Aged 65-85 Years of Age
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description: Percentage of women 65-85 years of age who ever had a centralContinue reading “2025 #39 MIPS Measure Screening for Osteoporosis for Women Aged 65-85 Years of Age”
2025 #24 MIPS Measure Communication with the Physician or Other Clinician Managing On-Going Care Post-Fracture for Men and Women Aged 50 Years and Older
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process – High Priority Description: Percentage of patients aged 50 years and older treatedContinue reading “2025 #24 MIPS Measure Communication with the Physician or Other Clinician Managing On-Going Care Post-Fracture for Men and Women Aged 50 Years and Older”
2025 #8 MIPS Measure Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description: Percentage of patients aged 18 years and older with a diagnosis ofContinue reading “2025 #8 MIPS Measure Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)”
2025 #7 MIPS Measure Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF ≤ 40%)
2025 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process Description: Percentage of patients aged 18 years and older with a diagnosis ofContinue reading “2025 #7 MIPS Measure Coronary Artery Disease (CAD): Beta-Blocker Therapy – Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF ≤ 40%)”